#868: Tim’s Founder Kitchen — From Brainstorm to The President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)
Jun 2, 2026 · 2h 15m
Ads
5
Brands
2
Inserted
0
Transcript
25k words
Ads in this episode
EP · The Tim Ferriss Show · #868: Tim’s Founder Kitchen — From Brainstorm to The President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)2:15:12
25:50host read
Incogni
code TIM
26:34host read
Helix Sleep
helixleep.com/tim
2:12:41host read
Helix Sleep
helixsleep.com/tim
2:14:15host read
Incogni
post-roll
| At | Brand | Type | Placement | Promo code | URL | Found by |
|---|---|---|---|---|---|---|
| 25:50–26:33 | Incogni | host readaudio feed | mid-roll | TIM | incogni.com/tim | trigger |
| 26:34–27:40 | Helix Sleep | host readaudio feed | mid-roll | helixleep.com/tim | trigger | |
| 2:12:41–2:13:46 | Helix Sleep | host readaudio feed | post-roll | helixsleep.com/tim | trigger | |
| 2:14:15–2:14:39 | Incogni | host readaudio feed | post-roll | trigger | ||
| 2:14:55–2:15:07 | Incogni | host readaudio feed | post-roll | TIM | incogni.com/tim | trigger |
Transcript
asr · 24,862 words · docs
0:00In genetic medicine, I would call it the holy grail for the last 30 years has been thinking about how do we administer intravenous, which means into the bloodstream, genetic medicines that can get to places throughout the body.
0:15We've been trapped in one organ for the past 30 years, and that's the liver.
0:24We are the first company that I'm aware of to show this extent of absculpal response in visceral, deep organ metastases in a multitude of patients.
0:36And really right off the bat, what I want the world to understand is that we are standing right now on the precipice of a revolution in genetic medicine.
0:48We're going to be able to get to a point in the not too distant future where I think a lot of types of cancers are, at the very least, chronic diseases instead of death sentences.
Full transcripts are coming soon
24,862 words with timestamps and ad segments marked. Join the waitlist for early access.